Anacardic Acid Mixture: Utilization of a Byproduct for the Sustainable Development of a Potential Antichagasic Agent Against Trypanosoma cruzi-Reference-Cited by-同舟云学术

Anacardic Acid Mixture: Utilization of a Byproduct for the Sustainable Development of a Potential Antichagasic Agent Against Trypanosoma cruzi

Published:2023-09-05 Issue:6 Volume:33 Page:1298-1302
ISSN:1981-528X
Container-title:Revista Brasileira de Farmacognosia
language:en
Short-container-title:Rev. Bras. Farmacogn.

Author:

Nogueira Tiago Rocha^ORCID,Figueredo Igor Mesquita^ORCID,Luciano João Henrique Silva^ORCID,Lima Antonio Calixto,da Fonseca Aluisio Marques^ORCID,Leal Luzia Kalyne Almeida Moreira^ORCID,Lima Mary Anne Sousa^ORCID,Martins Alice Maria Costa^ORCID,Marinho Emmanuel Silva^ORCID,de Queiroz Malveira Jackson,de Lima Neto Pedro^ORCID,Nunes Fátima Miranda^ORCID,de Sousa Rios Maria Alexsandra^ORCID,Pimenta Antônia Torres Ávila^ORCID

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Financiadora de Estudos e Projetos

Publisher

Springer Science and Business Media LLC

Subject

General Pharmacology, Toxicology and Pharmaceutics

Link

https://link.springer.com/content/pdf/10.1007/s43450-023-00453-z.pdf

Reference19 articles.

1. Barbosa H, Thevenard F, Quero RJ, Tempone AG, Honorio KM, Lago JHG (2023) The potential of secondary metabolites from plants as drugs or leads against Trypanosoma cruzi-an update from 2012 to 2021. Curr Top Med Chem 23:159–213. https://doi.org/10.2174/1568026623666221212111514

2. Chen Z, Cui Q, Cooper L, Zhang P, Lee H, Chen Z, Wang Y, Liu X, Rong L, Du R (2021) Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases. Cell Biosci 11:45. https://doi.org/10.1186/s13578-021-00564-x

3. Echeverría LE, Marcus R, Novick G, Estani SS, Ralston K, Zaidel EJ, Forsyth C, Ribeiro ALP, Mendoza I, Falconi ML, Mitelman J, Morillo CA, Pereiro AC, Pinazo MJ, Salvatella R, Martinez F, Pere P, Liprandi AS, Piñeiro DJ, Molina GR (2020) WHF IASC roadmap on Chagas disease. Glob Heart 15:26. https://doi.org/10.5334/GH.484

4. Freitas RF, Prokopczyk IM, Oliva G, Andricopulo AD, Trevisan MTS, Vilegas W, Silva MGV (2009) Discovery of novel Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase inhibitors. Bioorganic Med Chem 17:2476–2482. https://doi.org/10.1016/j.bmc.2009.01.079

5. Gondim FL, Ferreira RM, Nogueira TR, Serra DS, Rios SMA, Pimenta ATA, Cavalcante FSA (2021) Effects of anacardic acid monoene on the respiratory system of mice submitted to acute respiratory distress syndrome. Rev Bras Farmacogn 31:232–238. https://doi.org/10.1007/s43450-021-00151-8